Adjuvant Capital

Venture Capital

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges.

New York, United States · 8+ investments

Seed
Biotech
Healthcare
Life Sciences
Medical Devices
Headquarters
New York, United States
Founded
2018
AUM
$300.0M
Total Investments
8
Last Investment
Feb 2023
Geographic Focus
Global

Investment Thesis

Life sciences venture capital firm financing promising technologies including drugs, vaccines, diagnostics, and medical devices to address high-burden global public health challenges.

Adjuvant Capital is a Venture Capital firm based in New York, United States. It has made 8 investments in Biotech and Healthcare.

Investment History

Sign up to view investment history

Create a free account — 10 credits a month to unlock deal history, amounts, and round details.